Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

0.35

Margin Of Safety %

11

Put/Call OI Ratio

1.05

EPS Next Q Diff

0.03

EPS Last/This Y

2.32

EPS This/Next Y

0.52

Price

92.96

Target Price

102.35

Analyst Recom

1.66

Performance Q

11.41

Relative Volume

0.69

Beta

0.35

Ticker: AZN




19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2025-12-26AZN92.920.743.81119014
2025-12-29AZN92.530.791.40123981
2025-12-30AZN92.50.790.99124501
2025-12-31AZN91.940.791.04124799
2026-01-02AZN91.590.791.44124888
2026-01-05AZN91.210.809.17125568
2026-01-06AZN94.820.920.86132654
2026-01-07AZN95.120.920.48134142
2026-01-08AZN94.020.931.27134709
2026-01-09AZN94.640.923.56135128
2026-01-12AZN93.640.940.79137143
2026-01-13AZN94.510.941.14137431
2026-01-14AZN96.350.950.80139074
2026-01-15AZN940.960.38139242
2026-01-16AZN94.40.950.09139163
2026-01-20AZN89.951.110.6278712
2026-01-21AZN90.551.100.4180260
2026-01-22AZN91.71.070.3081764
2026-01-23AZN92.961.050.6482923
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1




19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-12-26AZN92.913.95295.54.59
2025-12-29AZN92.533.95517.34.59
2025-12-30AZN92.503.95504.24.59
2025-12-31AZN91.943.95289.94.59
2026-01-02AZN91.593.95229.74.59
2026-01-05AZN91.213.95609.24.59
2026-01-06AZN94.933.96410.64.59
2026-01-07AZN95.173.96367.84.59
2026-01-08AZN94.013.95145.14.59
2026-01-09AZN94.653.95678.24.59
2026-01-12AZN93.653.95475.54.59
2026-01-13AZN94.503.95803.64.59
2026-01-14AZN96.353.96190.34.59
2026-01-15AZN94.003.95395.94.59
2026-01-16AZN94.403.95839.14.59
2026-01-20AZN89.943.45059.14.59
2026-01-21AZN90.543.45780.84.59
2026-01-22AZN91.673.46205.94.59
2026-01-23AZN92.963.46190.74.59
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-12-26AZN0.00-0.710.27
2025-12-29AZN0.00-0.730.27
2025-12-30AZN0.00-0.730.27
2025-12-31AZN0.00-0.730.27
2026-01-02AZN0.00-0.730.27
2026-01-05AZN0.00-0.720.27
2026-01-06AZN0.00-0.720.27
2026-01-07AZN0.00-0.720.27
2026-01-08AZN0.00-0.720.27
2026-01-09AZN0.00-0.720.27
2026-01-12AZN0.00-3.840.27
2026-01-13AZN0.00-3.840.35
2026-01-14AZN0.00-3.840.35
2026-01-15AZN0.00-3.840.35
2026-01-16AZN0.00-3.840.35
2026-01-20AZN0.00-3.900.35
2026-01-21AZN0.00-3.900.35
2026-01-22AZN0.00-3.900.35
2026-01-23AZN0.00-3.900.35
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS

1.19

Avg. EPS Est. Current Quarter

1.09

Avg. EPS Est. Next Quarter

1.22

Insider Transactions

Institutional Transactions

-3.9

Beta

0.35

Average Sales Estimate Current Quarter

15430

Average Sales Estimate Next Quarter

14492

Fair Value

103.54

Quality Score

93

Growth Score

97

Sentiment Score

33

Actual DrawDown %

3.7

Max Drawdown 5-Year %

-27.9

Target Price

102.35

P/E

30.83

Forward P/E

18.1

PEG

1.52

P/S

4.96

P/B

6.28

P/Free Cash Flow

22.22

EPS

3.01

Average EPS Est. Cur. Y​

4.59

EPS Next Y. (Est.)

5.12

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

16.19

Relative Volume

0.69

Return on Equity vs Sector %

-6.8

Return on Equity vs Industry %

-16.3

EPS 1 7Days Diff

EPS 1 30Days Diff

0.03

EBIT Estimation

6190.7
Astrazeneca PLC
Sector: Healthcare
Industry: Drug Manufacturers - General
Employees: 94300
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Crestor, Seloken, Lokelma, Roxadustat, Andexxa, Wainua, Symbicort, Fasenra, Pulmicort, Breztri/Trixeo, Saphnelo, Tezspire, Airsupra, Ultomiris, Soliris, Strensiq, Koselugo, Kanuma, Atacand, Plendil, Modip, Splendil, Munobal, Flodil, Komboglyze, Qtern, Byetta, XIGDUO, Accolate, Accoleit, Vanticon, Beyfortus, Synagis, FluMist, tixagevimab and cilgavimab, and sipavibart. It also provides Bricanyl Respules, Eklira Genuair/Tudorza/Bretaris, Bricanyl Turbuhaler, Rhinocort, Bevespi Aerosphere, Daliresp/Daxas, Oxis Turbuhaler, Breztri Aerosphere, Duaklir Genuair, Kavigale, Evusheld, Fluenz/FluMist, and Voydeya. The company offers its products for ocology, cardiovascular, renal and metabolism, respiratory & immunology, vaccines and immune, and therapies rare diseases. It serves primary and specialty care physicians through distributors and local representative offices in the United Kingdom, the United States, Europe, and Asia. It has a strategic agreement with Tempus to develop the largest multimodal foundation model in oncology. The company has a collaboration agreement with IonQ, Inc. for the development of quantum-accelerated computational chemistry workflow for healthcare, life sciences, and chemistry; a strategic research collaboration with CSPC Pharmaceutical Group Limited to advance the discovery and development of novel oral candidates, with the potential to treat diseases across multiple indications; and collaboration Revna Biosciences for lung cancer treatment. AstraZeneca PLC was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
stock quote shares AZN – AstraZeneca PLC Stock Price stock today
news today AZN – AstraZeneca PLC stock forecast ,stock prediction 2023 2024 2025
marketwatch AZN – AstraZeneca PLC yahoo finance google finance
stock history AZN – AstraZeneca PLC invest stock market
stock prices AZN premarket after hours
ticker AZN fair value insiders trading